These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6687612)

  • 1. Functional activities of the NCTC 1469 macrophage-like cell line: comparison of the NCTC 1469 cell line with various other macrophage-like cell lines.
    De Weger RA; Van Loveren H; Van Basten CD; Oskam R; Van Der Zeijst BA; Den Otter W
    J Reticuloendothel Soc; 1983 Jan; 33(1):55-66. PubMed ID: 6687612
    [No Abstract]   [Full Text] [Related]  

  • 2. NCTC 1469 CB, a subline of the macrophage-like cell line NCTC 1469 with reduced phagocytic activity.
    Van Basten CD; De Weger RA; Van Loveren H
    J Reticuloendothel Soc; 1983 Jan; 33(1):47-53. PubMed ID: 6834359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous C1q reconstitutes a secondary deficiency of C5-deficient AKR mouse macrophages for FcR-dependent cellular cytotoxicity and phagocytosis.
    Leu RW; Zhou AQ; Kennedy MJ; Shannon BJ
    J Immunol; 1991 Feb; 146(4):1233-9. PubMed ID: 1991965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction of the tumoricidal activity of human and murine peritoneal macrophages under the action of antitumor chemical preparations].
    Potapov SL; Viadro MM
    Biull Eksp Biol Med; 1989 Sep; 108(9):330-2. PubMed ID: 2611394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 6. Down regulation of RNA labeling as a selective marker for cytotoxic but not suppressor macrophages.
    Varesio L
    J Immunol; 1984 Jun; 132(6):2683-5. PubMed ID: 6202756
    [No Abstract]   [Full Text] [Related]  

  • 7. Membrane changes in murine macrophages after in-vivo stimulation and activation.
    Glass EJ; Stewart J; Weir DM
    Immunology; 1983 Sep; 50(1):165-73. PubMed ID: 6350168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis.
    Miner KM; Nicolson GL
    Cancer Res; 1983 May; 43(5):2063-7. PubMed ID: 6687559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Fc-receptor expression and Fc-mediated phagocytosis in variants of a macrophage-like cell line.
    Schneck J; Rosen OM; Diamond B; Bloom BR
    J Immunol; 1981 Feb; 126(2):745-9. PubMed ID: 6256444
    [No Abstract]   [Full Text] [Related]  

  • 10. Surface antigens of the murine cytostatic peritoneal macrophage.
    Hogg N; Parish CR
    Immunology; 1980 Sep; 41(1):187-93. PubMed ID: 6933136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical separation of two distinct Fc receptors on murine macrophage-like cell lines.
    Anderson CL; Grey HM
    J Immunol; 1978 Aug; 121(2):648-52. PubMed ID: 681752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity.
    Kaplan AM; Bear HD; Kirk L; Cummins C; Mohanakumar T
    J Immunol; 1978 Jun; 120(6):2080-5. PubMed ID: 659893
    [No Abstract]   [Full Text] [Related]  

  • 13. Soluble factor(s) from LPS-activated macrophages induce cytotoxic T cell differentiation from alloantigen-primed spleen cells.
    Klimpel GR
    J Immunol; 1980 Sep; 125(3):1243-9. PubMed ID: 6967896
    [No Abstract]   [Full Text] [Related]  

  • 14. The activities of elastase and other lysosomal enzymes in professional phagocytes and mechanism of their release.
    Ferencík M; Stefanovic J; Kotulová D
    Acta Biol Med Ger; 1982; 41(1):31-4. PubMed ID: 6287772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cloned cell line, Mk1, possessing Ia antigens and accessory cell activity.
    Kyoizumi S; Noro N; Teshigawara K; Sakaguchi S; Masuda T
    J Immunol; 1982 Jun; 128(6):2586-94. PubMed ID: 6951877
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of macrophage heterogeneity by their phagocytic activity].
    Shcherbukhin VV; Rodionov SV; Nikolaeva EN; Zemskov VM
    Tsitologiia; 1986 Dec; 28(12):1299-306. PubMed ID: 3824521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inoculation with neuraminidase-treated tumor cells on macrophage cytotoxicity in vitro.
    Alley CD; Snodgrass MJ
    Cancer Res; 1978 Aug; 38(8):2332-8. PubMed ID: 667829
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneal macrophage cytotoxicity induced by serum in vitro.
    Lejeune FJ; Beaumont L; Garcia Y; Regnier R
    Biomedicine; 1978; 28(1):48-54. PubMed ID: 667276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lymphoid cell growth by a lipid-like component of macrophage hybridoma cells.
    Stallcup KC; Liu YN; Dorf ME; Mescher MF
    J Immunol; 1986 Apr; 136(8):2723-8. PubMed ID: 3958487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The generation of macrophage-like cell lines by transfection with SV40 origin defective DNA.
    Schwarzbaum S; Halpern R; Diamond B
    J Immunol; 1984 Mar; 132(3):1158-62. PubMed ID: 6319490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.